Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Change in Taxes: 2015-2024

Historic Change in Taxes for Protagonist Therapeutics (PTGX) over the last 9 years, with Dec 2024 value amounting to $2.7 million.

  • Protagonist Therapeutics' Change in Taxes fell 179.44% to -$1.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.6 million, marking a year-over-year decrease of 173.53%. This contributed to the annual value of $2.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Protagonist Therapeutics' Change in Taxes is $2.7 million, which was up 200.11% from -$2.7 million recorded in FY2022.
  • Over the past 5 years, Protagonist Therapeutics' Change in Taxes peaked at $2.7 million during FY2024, and registered a low of -$2.7 million during FY2022.
  • Its 2-year average for Change in Taxes is $1,500, with a median of $1,500 in 2022.
  • Per our database at Business Quant, Protagonist Therapeutics' Change in Taxes surged by 201.91% in 2020 and then slumped by 251.32% in 2022.
  • Over the past 4 years, Protagonist Therapeutics' Change in Taxes (Yearly) stood at $1.4 million in 2020, then climbed by 23.44% to $1.8 million in 2021, then tumbled by 251.32% to -$2.7 million in 2022, then reached $2.7 million in 2024.